How short is too short for amyloid fibrils?: Molecular dynamics of oligomers of infectious prion core structures

Efrosini Artikis1, Amitava Roy2, Byron Caughey1

  • 1Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.

Insights

Prion fibril fragments as small as tetramers maintain structural integrity, suggesting they may represent bioactive oligomers in proteinopathies. Spontaneous fragmentation appears unlikely in vivo.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Structural Biology

Background:

  • Amyloid fibrils and oligomers are implicated in proteinopathies, but their relative roles and conformations are often unclear.
  • Infectious prion protein (PrP) prions are typically fibrillar, and their potential dissociation into smaller, bioactive oligomers is debated.
  • Previous studies suggest prion amyloid fibrils can disassemble into smaller units, but this is contested.

Purpose of the Study:

  • To investigate the conformational stability of small prion fibril fragments (dimers to 25-mers) using molecular dynamics simulations.
  • To determine if these fragments can retain their structural integrity and templating surfaces.
  • To assess the potential for spontaneous fragmentation of prion oligomers.

Main Methods:

  • Molecular dynamics simulations of prion fibril core fragments ranging from dimers to 25-mers.
  • Analysis of secondary and tertiary structure retention and templating surface integrity.
  • Simulations conducted under various conditions, including elevated temperatures, across different prion strains (aRML, 22L, 263K).

Main Results:

  • Prion dimers rapidly lost structural integrity, while trimers retained some intermolecular beta-sheets.
  • Larger fragments (octamers and 25-mers) maintained significant structural motifs and templating surfaces, even at elevated temperatures.
  • No spontaneous fragmentation of core structures was observed for any tested prion strain, though terminal chains were destabilized.

Conclusions:

  • Oligomeric fragments of prion fibril cores, as small as tetramers, possess substantial structural integrity.
  • These stable oligomers could account for bioactive species detected in amyloidoses.
  • The lack of spontaneous fragmentation suggests in vivo prion oligomers may be rare or formed through specific cleavage processes.